S100A9 (myeloid-related protein 14), implicated in the abnormal differentiation of myeloid cells in the cancer stroma, contributes to create an immunosuppressive microenvironment that inhibits the generation of a protective cellular immune response by the tumor-bearing host [22]. Here, S100A9 is linked to neoplasm.